E-Learning

U.S. Treasuries extended a sharp retreat on Tuesday as investors were having to sell bonds to cover losses in other assets and scrambled to unwind expectations for deep U.S. rate cuts, in the latest unsettling sign of possible stress in financial markets. Monday's range for the benchmark 10-year yield was one of the largest in the past two decades while expectations evaporated that the Federal Reserve would start cutting interest rates within weeks to offset the economic pain caused by huge U.S. import tariffs. Market participants said the scale of moves and uncertainty in Fed funds futures trade was unprecedented, as pricing for 130 basis points of U.S. rate cuts this year collapsed to 92 bps in a matter of hours.

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how home construction materials stocks fared in Q4, starting with Simpson (NYSE:SSD).

The past six months haven’t been great for Sarepta Therapeutics. It just made a new 52-week low of $52, and shareholders have lost 56.6% of their capital. This may have investors wondering how to approach the situation.

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the aerospace industry, including HEICO (NYSE:HEI) and its peers.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Comcast (NASDAQ:CMCSA) and the best and worst performers in the wireless, cable and satellite industry.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at vertical software stocks, starting with Agilysys (NASDAQ:AGYS).

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the specialty retail industry, including National Vision (NASDAQ:EYE) and its peers.

Even during a down period for the markets, Kratos has gone against the grain, climbing to $28.94. Its shares have yielded a 15.4% return over the last six months, beating the S&P 500 by 26%. This run-up might have investors contemplating their next move.

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the online marketplace stocks, including Cars.com (NYSE:CARS) and its peers.

West Pharmaceutical Services has gotten torched over the last six months - since October 2024, its stock price has dropped 29.3% to $202.47 per share. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.